55 min
Science and Innovation in Israel: Past, Present and Future by Prof. Ruth Arnon American Friends Of Israel
-
- Education
An interesting episode with prof. ruth arnon, renowned immunologist and Eran Broshy Chairman of the American Friend of the Open University of Israel. Science and innovation in Israel: past, present, and future. Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.
We would appreciate your help in supporting the American Friends of The Open University of Israel - www.afoui.org
American Friends of the Open University of Israel, Inc. (AFOUI) was incorporated as a not-for-profit corporation in 1981 to build awareness of the Open University of Israel (OUI) in the United States and raise funds in order to provide grants to OUI to support the students, faculty, and growth initiatives of the OUI. We extend our heartfelt thanks to you - our sponsors, donors, friends, and colleagues. Your vital support is the foundation upon which the successes of the OUI have been built and upon which all its future achievements depend. We invite you to join us in our life-changing mission to further the goals of the OUI, a pioneer and cutting-edge leader in distance learning, dedicated to educating all those who would otherwise be denied a university education and to perpetuating the academic and intellectual traditions of the Jewish people.
We would appreciate your help in supporting the American Friends of The Open University of Israel - www.afoui.org
---
Send in a voice message: https://podcasters.spotify.com/pod/show/afoui/message
An interesting episode with prof. ruth arnon, renowned immunologist and Eran Broshy Chairman of the American Friend of the Open University of Israel. Science and innovation in Israel: past, present, and future. Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.
We would appreciate your help in supporting the American Friends of The Open University of Israel - www.afoui.org
American Friends of the Open University of Israel, Inc. (AFOUI) was incorporated as a not-for-profit corporation in 1981 to build awareness of the Open University of Israel (OUI) in the United States and raise funds in order to provide grants to OUI to support the students, faculty, and growth initiatives of the OUI. We extend our heartfelt thanks to you - our sponsors, donors, friends, and colleagues. Your vital support is the foundation upon which the successes of the OUI have been built and upon which all its future achievements depend. We invite you to join us in our life-changing mission to further the goals of the OUI, a pioneer and cutting-edge leader in distance learning, dedicated to educating all those who would otherwise be denied a university education and to perpetuating the academic and intellectual traditions of the Jewish people.
We would appreciate your help in supporting the American Friends of The Open University of Israel - www.afoui.org
---
Send in a voice message: https://podcasters.spotify.com/pod/show/afoui/message
55 min